Surgery Websites
Transplant Surgery »  Meet the Team »  Gastroenterology »  Jonathan P. Terdiman, M.D.
Jonathan P. Terdiman, M.D.

Jonathan P. Terdiman, M.D.

Professor of Clinical Medicine and Surgery
Chief, Clinical Gastroenterology
Associate Director, Colitis and Crohn's Disease Center
Director, Hereditary Gastrointestinal Cancer Prevention Program

Contact Information

Academic Office
Division of Gastroenterology
2330 Post Street, Suite 610
San Francisco, CA 94115
Phone: (415) 353-7906
Fax: 415-502-2249
Jonathan.Terdiman@ucsf.edu
Gastroenterology at Mount Zion
2330 Post St., Suite 610
San Francisco, CA 94115
Phone: (415) 502-4444
Fax: (415) 502-2249
Hours: Monday to Friday
9 a.m. - 4:30 p.m.
Inflammatory Bowel Disease Center
2330 Post St., Sixth Floor
San Francisco, CA 94115
Phone: (415) 502-4444
Fax: (415) 502-2249

Cancer Risk Program
1600 Divisadero St., Second Floor
San Francisco, CA 94143-1714
Phone: (415) 885-7779
Open Popup
  • 1981-85 College, Princeton University, A.B., cum laude
  • 1985-89 Medical School, Columbia University, College of Physicians and Surgeons, M.D
  • 1989-1990 Internship, Internal Medicine, University of California, San Francisco
  • 1990-1992 Residency, Internal Medicine, University of California, San Francisco
  • 1992-1993 Fellowship, Critical Care Medicine, University of California, San Francisco
  • 1993-1996 Fellowship, Gastroenterology, University of California, San Francisc
  • American Board of Internal Medicine, Diplomate in Internal Medicine
  • American Board of Internal Medicine, Diplomate in Gastroenterology
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • Division of Colorectal Surgery, Department of Surgery
  • Gastrointestinal Cancer Prevention Program
  • Colitis and Crohn's Disease Center
  • Colorectal cancer prevention and risk identification
  • Prognostic and predictive biomarkers in IBD

Jonathan Terdiman, M.D. is co-director of the Center for Inflammatory Bowel Disease and the Colorectal Cancer Prevention Program at UCSF Medical Center. His research interests include colorectal cancer prevention, hereditary gastrointestinal cancer and inflammatory bowel disease. He frequently lectures in the community, at the university and for various professional organizations on these subjects.

Terdiman earned a medical degree at Columbia University, College of Physicians and Surgeons. He went on to complete a residency in internal medicine and fellowships in critical care medicine and gastroenterology at UCSF where he is a professor of clinical medicine and surgery.

Dr. Terdiman's research interests are related to clinical and translational research in the areas of colorectal cancer prevention, especially among individuals at high risk for cancer, such as those with hereditary cancer syndromes or those with longstanding inflammatory bowel disease. Particular areas of interest include the optimal provision of genetic counseling and testing, cancer risk factor
identification and risk mitigation by interventions such as drugs (chemoprevention) and colonoscopy. 

Dr. Terdiman also studies the use of genetic and genomic markers to determine cancer risk and prognosis and prediction of response to therapy among those already diagnosed with cancer. He also is interested in projects related to biomarkers of prognosis and prediction of response to therapies in patients with inflammatory bowel disease.

MOST RECENT PUBLICATIONS FROM A TOTAL OF 107
Publications provided by UCSF Profiles, powered by CTSI.
  1. Lee JK, Kidambi TD, Kaltenbach T, Bhat YM, Shergill A, McQuaid KR, Terdiman JP, Soetikno RM. Impact of observational training on endoscopic mucosal resection outcomes and competency for large colorectal polyps: single endoscopist experience. Endosc Int Open. 2020 Mar; 8(3):E346-E353. View in PubMed
  2. Kotwani P, Terdiman J, Lewin S. Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience. J Crohns Colitis. 2020 Feb 05. View in PubMed
  3. Singh S, Allegretti JR, Siddique SM, Terdiman JP. AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology. 2020 Apr; 158(5):1465-1496.e17. View in PubMed
  4. Selvig D, Piceno Y, Terdiman J, Zydek M, Umetsu SE, Balitzer D, Fadrosh D, Lynch K, Lamere B, Leith T, Kassam Z, Beck K, Lewin S, Ma A, Somsouk M, Lynch SV, El-Nachef N. Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study. Dig Dis Sci. 2020 Apr; 65(4):1099-1106. View in PubMed
  5. Gutin L, Piceno Y, Fadrosh D, Lynch K, Zydek M, Kassam Z, LaMere B, Terdiman J, Ma A, Somsouk M, Lynch S, El-Nachef N. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile. United European Gastroenterol J. 2019 07; 7(6):807-814. View in PubMed
  6. View All Publications

 

Site Directory
    X